These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 11306559)

  • 1. Folding of prion protein to its native alpha-helical conformation is under kinetic control.
    Baskakov IV; Legname G; Prusiner SB; Cohen FE
    J Biol Chem; 2001 Jun; 276(23):19687-90. PubMed ID: 11306559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The peculiar nature of unfolding of the human prion protein.
    Baskakov IV; Legname G; Gryczynski Z; Prusiner SB
    Protein Sci; 2004 Mar; 13(3):586-95. PubMed ID: 14767078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expansion of the octarepeat domain alters the misfolding pathway but not the folding pathway of the prion protein.
    Leliveld SR; Stitz L; Korth C
    Biochemistry; 2008 Jun; 47(23):6267-78. PubMed ID: 18473442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of disulfide bridge in the folding and stability of the recombinant human prion protein.
    Maiti NR; Surewicz WK
    J Biol Chem; 2001 Jan; 276(4):2427-31. PubMed ID: 11069909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Slow spontaneous α-to-β structural conversion in a non-denaturing neutral condition reveals the intrinsically disordered property of the disulfide-reduced recombinant mouse prion protein.
    Sang JC; Lee CY; Luh FY; Huang YW; Chiang YW; Chen RP
    Prion; 2012; 6(5):489-97. PubMed ID: 22987112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aggregation and fibrillization of the recombinant human prion protein huPrP90-231.
    Swietnicki W; Morillas M; Chen SG; Gambetti P; Surewicz WK
    Biochemistry; 2000 Jan; 39(2):424-31. PubMed ID: 10631004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. pH-dependent stability and conformation of the recombinant human prion protein PrP(90-231).
    Swietnicki W; Petersen R; Gambetti P; Surewicz WK
    J Biol Chem; 1997 Oct; 272(44):27517-20. PubMed ID: 9346881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physical studies of conformational plasticity in a recombinant prion protein.
    Zhang H; Stockel J; Mehlhorn I; Groth D; Baldwin MA; Prusiner SB; James TL; Cohen FE
    Biochemistry; 1997 Mar; 36(12):3543-53. PubMed ID: 9132005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural intermediates in the putative pathway from the cellular prion protein to the pathogenic form.
    Jansen K; Schäfer O; Birkmann E; Post K; Serban H; Prusiner SB; Riesner D
    Biol Chem; 2001 Apr; 382(4):683-91. PubMed ID: 11405232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the mechanism of alpha-helix to beta-sheet transition in the recombinant prion protein.
    Morillas M; Vanik DL; Surewicz WK
    Biochemistry; 2001 Jun; 40(23):6982-7. PubMed ID: 11389614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disease-associated F198S mutation increases the propensity of the recombinant prion protein for conformational conversion to scrapie-like form.
    Vanik DL; Surewicz WK
    J Biol Chem; 2002 Dec; 277(50):49065-70. PubMed ID: 12372829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oligomerization of the human prion protein proceeds via a molten globule intermediate.
    Gerber R; Tahiri-Alaoui A; Hore PJ; James W
    J Biol Chem; 2007 Mar; 282(9):6300-7. PubMed ID: 17210575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular model of an alpha-helical prion protein dimer and its monomeric subunits as derived from chemical cross-linking and molecular modeling calculations.
    Kaimann T; Metzger S; Kuhlmann K; Brandt B; Birkmann E; Höltje HD; Riesner D
    J Mol Biol; 2008 Feb; 376(2):582-96. PubMed ID: 18158160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Volume and energy folding landscape of prion protein revealed by pressure.
    Cordeiro Y; Kraineva J; Winter R; Silva JL
    Braz J Med Biol Res; 2005 Aug; 38(8):1195-201. PubMed ID: 16082459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydration and packing effects on prion folding and beta-sheet conversion. High pressure spectroscopy and pressure perturbation calorimetry studies.
    Cordeiro Y; Kraineva J; Ravindra R; Lima LM; Gomes MP; Foguel D; Winter R; Silva JL
    J Biol Chem; 2004 Jul; 279(31):32354-9. PubMed ID: 15173173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conformational pH dependence of intermediate states during oligomerization of the human prion protein.
    Gerber R; Tahiri-Alaoui A; Hore PJ; James W
    Protein Sci; 2008 Mar; 17(3):537-44. PubMed ID: 18218718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prion protein amyloid formation under native-like conditions involves refolding of the C-terminal alpha-helical domain.
    Cobb NJ; Apetri AC; Surewicz WK
    J Biol Chem; 2008 Dec; 283(50):34704-11. PubMed ID: 18930924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of Prion Protein Conformation Using Circular Dichroism Spectroscopy.
    Ellett LJ; Johanssen VA
    Methods Mol Biol; 2017; 1658():27-34. PubMed ID: 28861780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of disease-associated mutations on the folding pathway of human prion protein.
    Apetri AC; Surewicz K; Surewicz WK
    J Biol Chem; 2004 Apr; 279(17):18008-14. PubMed ID: 14761942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conformational polymorphism of the amyloidogenic peptide homologous to residues 113-127 of the prion protein.
    Satheeshkumar KS; Jayakumar R
    Biophys J; 2003 Jul; 85(1):473-83. PubMed ID: 12829502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.